Hangzhou Binjiang

Hangzhou Binjiang Pharmaceutical is a China-based pharmaceutical company specializing in the development, manufacture, and commercialization of active pharmaceutical ingredients (APIs) and finished dosage forms. The company has a strong historical focus on corticosteroid and hormone-based therapies, providing essential treatments for inflammatory and dermatological conditions. Operating out of the Binjiang District in Hangzhou, the firm maintains high-standard manufacturing facilities that comply with international GMP requirements. Their business model encompasses both domestic sales within the Chinese market and the export of high-quality chemical intermediates and APIs to global partners.